Abstract
Diabetes and perioperative hyperglycemia are common and associated with an increased risk of postoperative infections and other complications. Perioperative glycemic optimization can help mitigate this risk.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Lee TH, Marcantonio ER, Mangione CM, Thomas EJ, et al. Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation. 1999;8:1043–9.
Underwood P, Askari R, Hurwitz S, et al. Preoperative A1c and clinical outcomes in patients with diabetes undergoing major noncardiac surgical procedures. Diabetes Care. 2014;37:611–6.
Van den Boom W, Schroeder RA, Manning MW, et al. Effect of A1c and glucose on postoperative mortality in noncardiac and cardiac surgeries. Diabetes Care. 2018;41(4):782–8.
Kwon S, Thompson R, Dellinger P, et al. Importance of perioperative glycemic control in general surgery. Ann Surg. 2013;257(1):8–14.
Kotagal M, Symons RG, Hirsch IB, et al. Perioperative hyperglycemia and risk of adverse events among patients with and without diabetes. Ann Surg. 2015;261(1):97–103.
Frisch A, Chandra P, Siley D, et al. Prevalence and clinical outcome of hyperglycemia in the perioperative period in non cardiac surgery. Diabetes Care. 2010;33:1783–8.
Furnary AP, Gao G, Grunkemeier GL, et al. Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting. J Thorac Cardiovasc Surg. 2003;125(5):1007–21.
Umpierrez GE, Smiley D, Jacobs S, et al. Randomized study of basal bolus insulin therapy in the inpatient management of patients with type 2 diabetes undergoing general surgery (RABBIT 2 Surgery). Diabetes Care. 2011;34:256–61.
Dhatariya K, Levy N, Kilvert A, et al. Diabetes UK position statements and care recommendations: NHS diabetes guideline for the perioperative management of the adult patient with diabetes. Diabet Med. 2012;29:420–33.
Write LAC, Hirsch IB. The challenge of the use of glycemic biomarkers in diabetes: Reflecting on hemoglobin A1c, 1,5-anhydroglucitol, and the glycated proteins fructosamine and albumin. Diabetes Spectr. 2012;25:141–8.
Duggan EW, Carlson K, Umpierrez GE. Perioperative hyperglycemia management: an update. Anesthesiology. 2017;126(3):547–60.
Upierrez GI, Hellman R, Korytkowski MT, et al. Management of hyperglycemia in hospitalized patients in non-critical care setting: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2012;97:16.
American Diabetes Association Standards of medical care in diabetes–2017. Diabetes Care. 2017;40(5 Suppl. 1):S120–7.
Moghissi ES, Korytkowski MT, DiNardo M, et al. American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control. Endocr Pract. 2009;15(4):1–17.
Lazar HL, McDonnell M, Chipkin SR, et al. The society of thoracic surgeons practice guideline series: blood glucose management during adult cardiac surgery. Ann Thorac Surg. 2009;87:663–9.
American Diabetes Association Diabetes care in the hospital. Diabetes Care. 2017;40(Suppl. 1):S120–7.
Buchleitner AM, Martinez-Alonso M, Hernandez M, et al. Perioperative glycaemic control for diabetic patients undergoing surgery. Cochrane Database Syst Rev. 2012;(9):CD007315.
The NICE-STUDY Investigators. Intensive versus conventional glucose control in critically ill patients. NEJM. 2009;360(13):1283–97.
U.S. Food and Drug Administration. FDA drug safety communication: FDA revises labels of SGLT2 inhibitors for diabetes to include warnings about too much acid in the blood and serious urinary tract infections. Wilver Spring: U.S. Food and Drug Administration; 2018. Available at https://www.fda.gov/Drugs/DrugSafety/ucm475463.htm. Accessed 9 May 2016.
Handelsman Y, Henry RR, Bloomgarden ZT, et al. American Association of Clinical Endocrinologists and American College of Endocrinology position statement on the association of SGLT-2 inhibitors and diabetic ketoacidosis. Endocr Pract. 2016;22:753–62.
Rubino F, Gagner M, Gentileschi P, et al. The early effect of the Roux-En-Y gastric bypass on hormones involved in body weight regulation and glucose metabolism. Ann Surg. 2004;240(2):236–42.
Acknowledgments
Cora Espina, MN, ARNP, CWCN, Teaching Associate, Division of Endocrinology, UW School of Medicine.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Chen, T. (2020). Diabetes. In: Jackson, M., Huang, R., Kaplan, E., Mookherjee, S. (eds) The Perioperative Medicine Consult Handbook. Springer, Cham. https://doi.org/10.1007/978-3-030-19704-9_13
Download citation
DOI: https://doi.org/10.1007/978-3-030-19704-9_13
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-19703-2
Online ISBN: 978-3-030-19704-9
eBook Packages: MedicineMedicine (R0)